Jennifer Heller is an Associate Partner at McKinsey & Company based in Chicago. She is a leader in McKinsey’s Pharmaceuticals and Medical Products practice and co-leads the Vaccines and Biosimilars service lines with a focus on the US market. Heller has deep expertise in commercial and innovation strategy, particularly related to complex molecules and biologics including vaccines. She received her PhD in Immunology from Northwestern University and has prior research experience at Novartis Institutes for Biomedical Research in Basel, Switzerland. She has published in industry leading scientific journals including Immunity and Journal of Clinical Investigation, among others and is co-author of a recently published McKinsey paper, Refueling the innovation engine in vaccines.